[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hyperbilirubinemia-neonatal\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hyperbilirubinemia-neonatal":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100562483","role-of-serum-ba-ratio-compared-to-tsb-for-early-prediction-of-bilirubin-induced-neurological-dysfunction-bind-100562483",false,"NCT06603753","Role of Serum (B\u002FA) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).","Use of Serum Bilirubin\u002FAlbumin Ratio for Early Prediction of Bilirubin Induced Neurological Dysfunction","Inclusion Criteria:• Neonates with hyperbilirubinemia reached level of phototherapy or exchange transfusion according to the American Academy of Pediatrics guidelines \\[14\\].\n\n* Age: from 1 to 28 day.\n* Full term and preterm babies.\n* Both sexes.\n\nExclusion Criteria:\n\n* Conjugated hyperbilirubinemia.\n* Perinatal asphyxia.\n* Patients with encephalopathy due to causes other than hyperbilirubinemia.\n* Severe birth defects or congenital anomalies.\n* Hemodynamic instability.\n* Septic patients.",true,"ALL","1 Day","28 Days",{"count":21,"type":22},80,"ESTIMATED","OBSERVATIONAL","The aim of this study is to evaluate serum bilirubin\u002Falbumin (B\u002FA) ratio compared to total serum bilirubin (TSB) for early prediction of bilirubin-induced neurological dysfunction (BIND).",[26],"Hyperbilirubinemia, Neonatal","NOT_YET_RECRUITING","2024-09-17",{"date":30,"type":31},"2024-09-19","ACTUAL",{"date":33,"type":22},"2025-01-01",{"date":35,"type":22},"2026-07-01",{"name":37,"class":38},"alaa aboelhassan mohamed aboelhassan","OTHER",{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":17,"minAge":46,"maxAge":19,"enrollmentInfo":47,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":49,"conditions":50,"keywords":52,"overallStatus":56,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":66},"100352234","validation-of-a-jaundice-diagnostic-and-monitoring-device-for-low-resource-settings-100352234","NCT03866213","Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings","Validation of a Low-Cost, Point-of-Care Bilirubin Measurement to Diagnose Neonatal Jaundice and Monitor Phototherapy in Hospitals in Sub-Saharan Africa","Inclusion Criteria:\n\n* The patient is currently being treated at Queen Elizabeth Central Hospital or Kamuzu Central Hospital in the neonatal ward.\n* The patient is less than 28 days old (neonate).\n* The patient is deemed to be at risk for jaundice or the patient is undergoing blue light phototherapy for treatment of jaundice.\n* The patient's parent or guardian has provided informed consent for their child to participate.\n\nExclusion Criteria:\n\n* Parent or guardian is unable or unwilling to provide informed consent.\n* The patient is unable to receive a blood draw\u002Fheel stick as determined by their clinician.","0 Days",{"count":48,"type":22},1000,"A team of researchers at Rice University in partnership with clinicians at Queen Elizabeth Central Hospital created BiliSpec, a low-cost battery-powered reader designed to immediately quantify serum bilirubin levels from a small drop of whole blood applied to a lateral flow strip. The simple and affordable BiliSpec system offers a faster and more cost-effective means to detect neonatal jaundice in under-resourced clinics and determine when phototherapy is needed. The goal of this study is to validate the accuracy of the BiliSpec device in measuring bilirubin levels in neonates relative to the laboratory spectrophotometric bilirubinometer and transcutaneous bilirubinometer measurements.",[26,51],"Jaundice, Neonatal",[53,54,55],"Diagnostic","Point-of-Care","Low-Resource Setting","RECRUITING","2024-06-06",{"date":59,"type":31},"2024-06-07",{"date":61,"type":31},"2019-08-01",{"date":63,"type":22},"2024-08-31",{"name":65,"class":38},"William Marsh Rice University",3]